Fund Holdings — B Group, Inc.

Total Portfolio Value:
$176.19M
Total Bought:
$30.48M
Total Sold:
$2.25M
Net Transaction:
+$28.23M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ADMA BIOLOGICS INC3,207,5423,262,542+55,000$28.90M$27.31M15.50%-$1.59M
PALISADE BIO INC11,414,28511,414,2850$19.97M$23.86M13.54%+$3.88M
NRX PHARMACEUTICALS INC3,000,0004,091,767+1,091,767$6.39M$16.74M9.50%+$10.35M
FAETH THERAPEUTICS INC0610,169+610,169$0$15.25M8.66%+$15.25M
Taysha Gene Therapies, Inc.(TSHA)1,800,5561,800,5560$8.05M$12.26M6.96%+$4.21M
Praxis Precision Medicines, Inc.(PRAX)33,23733,2370$10.71M$11.13M6.32%+$418.8K
CELLECTIS S A3,281,5013,281,5010$10.40M$9.84M5.59%-$557.9K
Zai Lab Limited(ZLAB)450,646450,6460$8.48M$8.56M4.86%+$85.6K
STRUCTURE THERAPEUTICS INC127,500140,000+12,500$6.15M$7.51M4.26%+$1.37M
Oruka Therapeutics, Inc.(ORKA)75,00075,0000$3.68M$7.14M4.05%+$3.46M
Iovance Biotherapeutics, Inc.(IOVA)1,500,0001,500,0000$5.26M$6.24M3.54%+$975.0K
Spyre Therapeutics, Inc.(SYRE)100,00070,000-30,000$5.04M$6.21M3.53%+$1.17M
AURA BIOSCIENCES INC597,576764,243+166,667$4.00M$5.43M3.08%+$1.43M
ASSEMBLY BIOSCIENCES INC175,706175,7060$4.88M$4.83M2.74%-$47.4K
BRIGHT MINDS BIOSCIENCES INC67,50067,5000$4.93M$4.74M2.69%-$187.0K
Ultragenyx Pharmaceutical Inc.(RARE)135,000135,0000$2.83M$4.51M2.56%+$1.68M
SIGHT SCIENCES INC970,000970,0000$3.66M$3.66M2.08%$0
FOGHORN THERAPEUTICS INC102,000200,000+98,000$487.6K$976.0K0.55%+$488.4K
APOGEE THERAPEUTICS INC7,5000-7,500$631.3K$0—-$631.3K
Replimune Group, Inc.(REPL)26,0000-26,000$198.9K$0—-$198.9K
SOLENO THERAPEUTICS INC7,5000-7,500$251.1K$0—-$251.1K
Page 1 of 1
B Group, Inc. — 13F Holdings — Q2 2026 | TickerTrail